Brand check
Is Calpol banned in India?
Last checked 19 September 2026
Calpol is not banned in India as of 19 Sep 2026; it is single-ingredient paracetamol, which no Section 26A notification covers.
- Classification
- No ban or recall found in official records
- Decided by
- CDSCO / Ministry of Health and Family Welfare
- Reference
- No Section 26A notification for paracetamol
- Latest action
- 4 October 2025
- Last checked
- 19 September 2026
Calpol Six Plus advertisement (Wellcome Collection). Photo: Calpol Six Plus Wellcome L0068137.jpg by Unknown author (CC BY 4.0). Brand names and logos belong to their owners and are used here to identify the product this entry is about. All photo credits.
CDSCO: Drugs banned in India (consumer section)
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Governing authority
- CDSCO, Ministry of Health and Family Welfare
- Ban notification
- None
- Marketer
- GSK / Haleon (India)
- Paediatric syrup
- Not covered by the Oct 2025 DGHS advisory, which concerns cough syrups
- NSQ history
- Check individual batches against CDSCO monthly alerts
Where the claim comes from
Calpol is the paracetamol brand most associated with children, so the October 2025 advisory against cough syrups for under-2s and the 2025 to 2026 restrictions on chlorpheniramine + phenylephrine drops for under-4s produced 'is Calpol banned' searches. Neither action concerns paracetamol. The 2022 Dolo tax story and the 2024 FDC list added to it.
Calpol is a paracetamol brand sold as tablets and as a paediatric syrup. It is not banned in India, and no regulator has proposed banning it.
The government's recent actions on children's medicines are the reason for the question. On 4 October 2025 the Directorate General of Health Services advised that cough syrups should not be prescribed or dispensed to children below two years, after the deaths linked to diethylene-glycol-contaminated syrups. In April 2025 and again in August 2026 the Health Ministry required chlorpheniramine + phenylephrine products to carry a "not for children below four years" label. Both measures concern cough and cold products. Paracetamol syrup is a fever and pain medicine and is outside both.
Single-ingredient paracetamol has never been the subject of a Section 26A notification. The various FDC bans since 2016 removed combinations in which paracetamol is mixed with decongestants, antihistamines, muscle relaxants or opioids; they did not touch paracetamol alone.
What parents should still do is ordinary: dose by weight as advised, keep to the interval on the label, and check the batch number if a CDSCO alert names a paracetamol product. Batch-level findings, when they occur, are about one production lot, not the brand.
What this means for you
Safe to continue as directed
Calpol syrup and tablets are licensed; dose by weight for children as your doctor advised.
It is not a cough syrup
The 2025 advisory and the 2025 to 2026 label rules for children concern cough and cold combinations, not paracetamol.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Batches flagged in CDSCO alerts
Products whose name matches this brand or molecule in CDSCO monthly NSQ alerts. A flagged batch is a single batch; the company's response, where reported, is noted on the page above.
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Tolperisone & Paracetamol Tablets | TB26.084Mfg 2026-02 · Exp 2028-01 | Verax Life Sciences Pvt. LtdHimachal Pradesh | The sample does not conform to label claim with respect to content of Tolperisone HydrochlorideLabelling | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
| Paracetamol, Phenylephrine HCL, Guaiphenesin, Cetirizine Hydrochloride & Ambroxol HCL Tablets | SBT-3351Mfg 2025-07 · Exp 2027-06 | Supercure Biotech Pvt. LtdHaryana | The sample is found to be Not of Standard Quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab | Jul 2026 |
| Paracetamol Tablets IP 650mg. | AGT40557Mfg 2024-05 · Exp 2027-04 | Alventa Pharma LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | CDL,KolkataState lab | Jul 2026 |
| Paracetamol Tablets IP 650mg | FT5427Mfg 2025-10 · Exp 2027-09 | Forgo PharmaceuticalsHimachal Pradesh | The sample does not conforms to the I.P. with respect to Dissolution Test.Dissolution | DTL BikanerState lab | Jul 2026 |
| Paracetamol Tablets IP 650mg | T60095Mfg 2026-03 · Exp 2028-02 | Zenith Drugs Ltd. 72/5 & 72/3Madhya Pradesh | The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution | SDTL,GuwahatiState lab | Jul 2026 |
| Paracetamol Tablets IP 650 mg | UT-3765Mfg 2024-01 · Exp 2026-12 | Yacca Pharmaceutical Pvt. Ltd. 11 th KmUttarakhand | Dissolution testDissolution | SDT&RL, BhubaneswarState lab | Jul 2026 |
| Paracetamol Tablets IP 500mg | CHT-50351Mfg 2025-02 · Exp 2028-01 | Cotec Healthcare Pvt. LtdUttarakhand | The sample does not comply as per I.P. 2022 with respect to the test for Dissolution of Paracetamol.Dissolution | RDTL, GuwahatiCDSCO lab | Jul 2026 |
| Paracetamol Tablets IP 500 mg | PAK-825Mfg 2025-01 · Exp 2027-12 | Healer's Lab Unit IIHimachal Pradesh | The sample does not conform to the IP standards with respect to the test for DissolutionDissolution | DTL, ThrissurState lab | Jul 2026 |
| Paracetamol Paediatric Syrup IP 60 ml | PCS25194Mfg 2025-09 · Exp 2027-08 | Vivek Pharmachem(India) LtdRajasthan | The sample does not conform to IP standards. It fails the test Microbial Examination of Non- Sterile Product as per IP, as specified in the Laboratory protocol.Microbial limits | DTL, TVPMState lab | Jul 2026 |
| Nimesulide & Paracetamol Tablets | Not MentionedMfg ? · Exp ? | Euphoria India PharmaceuticalsHimachal Pradesh | MISBRANDED DRUGS.Misbranded | SFDTL UttarakhandState lab | Jul 2026 |
| Mefenamic Acid & Paracetamol Tablets | T-252174Mfg 2025-03 · Exp 2027-02 | Merril Pharma Pvt.LtdUttarakhand | The sample does not conform to Schedule V of the Drugs Rule 1945 with respect to the test disintegration.Disintegration | DTL, ThrissurState lab | Jul 2026 |
| Diclofenac Sodium and Paracetamol Tablets IP | I501103Mfg 2025-02 · Exp 2027-01 | Zydus Healthcare LtdSikkim | Description & DissolutionDissolution | Lucknow LabState lab | Jul 2026 |
| Diclofenac Sodium & Paracetamol Tablets | AHT-2502262Mfg 2026-02 · Exp 2028-01 | Aru Health Care Pvt. Ltd. - K-12 | Disintegration TestDisintegration | Lucknow LabState lab | Jul 2026 |
| Aceclofenac, Paracetamol and Serratiopeptidase Tablets | F9AHY065Mfg 2025-10 · Exp 2027-09 | Pharma Force Lab 53-55Himachal Pradesh | Identity test negative for Aceclofenac and Content of ParacetamolOther | Lucknow LabState lab | Jul 2026 |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets | TG25-1919BMfg 2025-10 · Exp 2027-09 | Menrik Biomerge Pvt. Ltd. 5Delhi | Content of AceclofenacOther | GORAKHPUR LAB, UPState lab | Jul 2026 |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets | FND0825055AKMfg 2025-12 · Exp 2028-05 | Ipca Laboratories Ltd. Unit-IISikkim | Identity test negative for Aceclofenac and ParacetamolOther | Lucknow LabState lab | Jul 2026 |
| Aceclofenac & Paracetamol Tablets IP | MT250239Mfg 2025-06 · Exp 2028-05 | Oxford PharmaUttarakhand | Content of Aceclofenac (82.94%)Other | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
| Aceclofenac & Paracetamol Tablets IP | T-2504296Mfg 2025-04 · Exp 2028-03 | Gopal LifesciencesHimachal Pradesh | DissolutionDissolution | Lucknow LabState lab | Jul 2026 |
| Aceclofenac & Paracetamol Tablets | T2601006/AMfg 2026-01 · Exp 2028-12 | Empree Medicament India Pvt. Ltd | Does not conform to IP Standards with respect to Dissolution TestDissolution | Food & Drugs Laboratory Bambolim, GoaState lab | Jul 2026 |
| Aceclofenac & Paracetamol Tablets | BLPT-053Mfg 2026-04 · Exp 2028-03 | Bonn Stering Bio Science LLP. Plot No. 64 & 65 Electronic parkPuducherry | Content of Aceclofenac (81.98%) and Paracetamol (81.62%)Other | Drugs Testing Laboratory, Madurai-19State lab | Jul 2026 |
Official sources and primary records
- Regulator
- AIR: Health ministry advises cough syrups should not be prescribed or dispensed to children below two yearsNewsAll India Radio · 4 October 2025
- Medical Dialogues: Health ministry restricts chlorpheniramine + phenylephrine FDCs for children below 4, mandates warning labelsNewsMedical Dialogues